{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:20:48Z","timestamp":1791231648881,"version":"4.1.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health Carlos III","award":["PI17\/01785"],"award-info":[{"award-number":["PI17\/01785"]}]},{"name":"National Institute of Health Carlos III","award":["P22\/00883"],"award-info":[{"award-number":["P22\/00883"]}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["PI-0130-2022"],"award-info":[{"award-number":["PI-0130-2022"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["MICIU\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MICIU\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERDF\/EU","award":["PID2022-141034OB-C22"],"award-info":[{"award-number":["PID2022-141034OB-C22"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The first year of haemodialysis (HD) carries the highest risk of mortality, which to a large extent is attributed to the aggravation of inflammation. However, traditional markers such as C-reactive protein and interleukin-6 show only minor changes during the first year, suggesting that there are other factors involved. The present study evaluates the effect of HD on microinflammation and oxidative stress of uremic patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a prospective observational longitudinal study including 30 incident HD patients. Blood samples were collected at baseline and 6 and 12\u00a0months. Pro-inflammatory monocytes were quantified using flow cytometry. Proteomic analysis (Olink) was performed on serum. Concentrations of indoxyl sulphate (IS), growth differentiation factor 15 (GDF-15), oxidative status and circulating microRNA (miRNA) expression were also determined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A new population of activated monocytes was identified that progressively increased at 1\u00a0year of HD. In addition, an increase in the serum concentration of up to 29 inflammation-related proteins was detected, including interleukins, chemokines, tumour necrosis factor family molecules, cell activation molecules and apoptosis-related proteins. Conversely, leukaemia inhibitory factor receptor was downregulated. The concentration of IS was positively correlated with GDF-15 levels. Furthermore, patients exhibited decreased expression of miRNA-126-3p, -130a-3p, -146a-5p, 223-3p, -let7a-5p and -let7b-5p.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study highlights the impact of HD on inflammation and oxidative stress, manifested by an increase in activated monocytes and inflammatory markers. The observed subclinical inflammation associated to HD treatment may help in understanding the mechanisms of cardiovascular damage in patients on HD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf223","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:54:38Z","timestamp":1752159278000},"source":"Crossref","is-referenced-by-count":6,"title":["New biomarkers of inflammation associated with haemodialysis"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-0574","authenticated-orcid":false,"given":"F\u00e1tima","family":"Guerrero","sequence":"first","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Carmona","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ariza","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]},{"name":"Dialysis Satellite Unit, Fresenius Medical Care Services Andaluc\u00eda , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Obrero","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Berdud","sequence":"additional","affiliation":[{"name":"Dialysis Satellite Unit, Fresenius Medical Care Services Andaluc\u00eda , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Carrillo-Carri\u00f3n","sequence":"additional","affiliation":[{"name":"Institute for Chemical Research (IIQ), CSIC-University of Seville , Seville ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagrario","family":"Soriano","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]},{"name":"Nephrology Service, Reina Sofia University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R","family":"Mu\u00f1oz-Casta\u00f1eda","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]},{"name":"Nephrology Service, Reina Sofia University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn-Malo","sequence":"additional","affiliation":[{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of C\u00f3rdoba, Reina Sof\u00eda University Hospital , C\u00f3rdoba ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2025081805020867800_bib1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"2025081805020867800_bib2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","article-title":"Epidemiology of haemodialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"2025081805020867800_bib3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1089\/ars.2020.8184","article-title":"Inflammation and oxidative stress in chronic kidney disease and dialysis patients","volume":"35","author":"Ebert","year":"2021","journal-title":"Antioxid Redox Signal"},{"key":"2025081805020867800_bib4","doi-asserted-by":"publisher","first-page":"3081856","DOI":"10.1155\/2017\/3081856","article-title":"Oxidative stress in hemodialysis patients: a review of the literature","volume":"2017","author":"Liakopoulos","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"2025081805020867800_bib5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/ckj\/sfv021","article-title":"The first year on haemodialysis: a critical transition","volume":"8","author":"Broers","year":"2015","journal-title":"Clin Kidney J"},{"key":"2025081805020867800_bib6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ekir.2022.10.020","article-title":"Biphasic dynamics of inflammatory markers following hemodialysis initiation: results from the international MONitoring dialysis Outcome Initiative","volume":"8","author":"Yousif","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025081805020867800_bib7","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1111\/j.1523-1755.2004.00656.x","article-title":"Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress","volume":"65","author":"Pupim","year":"2004","journal-title":"Kidney Int"},{"key":"2025081805020867800_bib8","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1523-1755.2004.989_10.x","article-title":"Microinflammation versus inflammation in chronic renal failure patients","volume":"66","author":"Tsirpanlis","year":"2004","journal-title":"Kidney Int"},{"key":"2025081805020867800_bib9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3389\/fimmu.2018.02845","article-title":"Chronic kidney disease severity is associated with selective expansion of a distinctive intermediate monocyte subpopulation","volume":"9","author":"Naicker","year":"2018","journal-title":"Front Immunol"},{"key":"2025081805020867800_bib10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.4049\/jimmunol.1001866","article-title":"Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity","volume":"186","author":"Merino","year":"2011","journal-title":"J Immunol"},{"key":"2025081805020867800_bib11","doi-asserted-by":"publisher","first-page":"9031452","DOI":"10.1155\/2018\/9031452","article-title":"Expansion of a population of large monocytes (atypical monocytes) in peripheral blood of patients with acute exacerbations of chronic obstructive pulmonary diseases","volume":"2018","author":"Yang","year":"2018","journal-title":"Mediat Inflamm"},{"key":"2025081805020867800_bib12","doi-asserted-by":"publisher","first-page":"e064540","DOI":"10.1136\/bmjopen-2022-064540","article-title":"Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019","volume":"13","author":"Feng","year":"2023","journal-title":"BMJ Open"},{"key":"2025081805020867800_bib13","doi-asserted-by":"publisher","first-page":"800950","DOI":"10.3389\/fphar.2022.800950","article-title":"Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025081805020867800_bib14","doi-asserted-by":"publisher","first-page":"9609266","DOI":"10.1155\/2023\/9609266","article-title":"The growing challenge of chronic kidney disease: an overview of current knowledge","volume":"2023","author":"Borg","year":"2023","journal-title":"Int J Nephrol"},{"key":"2025081805020867800_bib15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1681\/ASN.0000000000000083","article-title":"Chronic kidney disease is characterized by expansion of a distinct proinflammatory intermediate monocyte subtype and by increased monocyte adhesion to endothelial cells","volume":"34","author":"Cormican","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2025081805020867800_bib16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000350611","article-title":"Post-dilution high convective transport improves microinflammation and endothelial dysfunction independently of the technique","volume":"35","author":"Ariza","year":"2013","journal-title":"Blood Purif"},{"key":"2025081805020867800_bib17","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1681\/ASN.2006020105","article-title":"On-line hemodiafiltration reduces the proinflammatory CD14+CD16+ monocyte-derived dendritic cells: a prospective, crossover study","volume":"17","author":"Carracedo","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2025081805020867800_bib18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000321889","article-title":"Microinflammation in hemodialysis patients is associated with increased CD14+CD16+ pro-inflammatory monocytes: possible modification by on-line hemodiafiltration","volume":"31","author":"Kim","year":"2011","journal-title":"Blood Purif"},{"key":"2025081805020867800_bib19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/JLB.5CE0920-613R","article-title":"Atypical monocytes in COVID-19: lighting the fire of cytokine storm?","volume":"109","author":"Pence","year":"2021","journal-title":"J Leukoc Biol"},{"key":"2025081805020867800_bib20","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1038\/s41598-020-61022-1","article-title":"Identification of novel human monocyte subsets and evidence for phenotypic groups defined by interindividual variations of expression of adhesion molecules","volume":"10","author":"Merah-Mourah","year":"2020","journal-title":"Sci Rep"},{"key":"2025081805020867800_bib21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/toxins16050227","article-title":"A historical perspective on uremia and uremic toxins","volume":"16","author":"Meijers","year":"2024","journal-title":"Toxins (Basel)"},{"key":"2025081805020867800_bib22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/toxins9020052","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins (Basel)"},{"key":"2025081805020867800_bib23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12882-022-02862-z","article-title":"Serum total indoxyl sulfate levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study","volume":"23","author":"Li","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025081805020867800_bib24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/toxins13020142","article-title":"Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets","volume":"13","author":"Lim","year":"2021","journal-title":"Toxins (Basel)"},{"key":"2025081805020867800_bib25","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/ckj\/sfaa121","article-title":"Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study","volume":"14","author":"Yamamoto","year":"2021","journal-title":"Clin Kidney J"},{"key":"2025081805020867800_bib26","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 is an inflammation-induced central mediator of tissue tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"key":"2025081805020867800_bib27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.31083\/j.rcm2403081","article-title":"Role of the stress- and inflammation-induced cytokine GDF-15 in cardiovascular diseases: from basic research to clinical relevance","volume":"24","author":"Schwarz","year":"2023","journal-title":"Rev Cardiovasc Med"},{"key":"2025081805020867800_bib28","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.arr.2022.101569","article-title":"GDF15, an emerging key player in human aging","volume":"75","author":"Conte","year":"2022","journal-title":"Ageing Res Rev"},{"key":"2025081805020867800_bib29","doi-asserted-by":"publisher","first-page":"5163548","DOI":"10.1155\/2023\/5163548","article-title":"Growth differentiation factor 15 and risk of death in haemodialysis patients","volume":"2023","author":"Calen","year":"2023","journal-title":"Int J Nephrol"},{"key":"2025081805020867800_bib30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1515\/CCLM.2002.019","article-title":"Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation","volume":"40","author":"Gerardi","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"2025081805020867800_bib31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000070691","article-title":"Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure","volume":"21","author":"Samouilidou","year":"2003","journal-title":"Blood Purif"},{"key":"2025081805020867800_bib32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamacardio.2020.5392","article-title":"Association of circulating monocyte chemoattractant protein-1 levels with cardiovascular mortality: a meta-analysis of population-based studies","volume":"6","author":"Georgakis","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2025081805020867800_bib33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/jcm10051137","article-title":"MCP-1 predicts recurrent cardiovascular events in patients with persistent inflammation","volume":"10","author":"Blanco-Colio","year":"2021","journal-title":"J Clin Med"},{"key":"2025081805020867800_bib34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ndt\/17.3.435","article-title":"Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events","volume":"17","author":"Papayianni","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2025081805020867800_bib35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1159\/000082936","article-title":"Possible new role of monocyte chemoattractant protein-1 in hemodialysis patients with cardiovascular disease","volume":"24","author":"Pawlak","year":"2004","journal-title":"Am J Nephrol"},{"key":"2025081805020867800_bib36","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey","volume":"119","author":"Aggarwal","year":"2012","journal-title":"Blood"},{"key":"2025081805020867800_bib37","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/ndt\/gfq823","article-title":"Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up","volume":"26","author":"Desideri","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2025081805020867800_bib38","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/cells9122589","article-title":"Soluble CD5 and CD6: lymphocytic class I scavenger receptors as immunotherapeutic agents","volume":"9","author":"Velasco-de Andr\u00e9s","year":"2020","journal-title":"Cells"},{"key":"2025081805020867800_bib39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.7150\/ijms.5063","article-title":"Plasma brain-derived neurotrophic factor in hemodialysis patients","volume":"9","author":"Shin","year":"2012","journal-title":"Int J Med Sci"},{"key":"2025081805020867800_bib40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/ndt\/15.5.589","article-title":"Glial cell line-derived neurotrophic factor (GDNF) is expressed in the human kidney and is a growth factor for human mesangial cells","volume":"15","author":"Orth","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2025081805020867800_bib41","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1093\/ndt\/gfr485","article-title":"Circulating microRNA expression is reduced in chronic kidney disease","volume":"26","author":"Neal","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2025081805020867800_bib42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2174\/2211536611302010007","article-title":"Circulating microRNAs as biomarkers for inflammatory diseases","volume":"2","author":"Mi","year":"2013","journal-title":"MicroRNA"},{"key":"2025081805020867800_bib43","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ndt\/gfac220","article-title":"The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function","volume":"38","author":"Vergara","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025081805020867800_bib44","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/ckj\/sfad017","article-title":"A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients","volume":"16","author":"Bolignano","year":"2023","journal-title":"Clin Kidney J"},{"key":"2025081805020867800_bib45","doi-asserted-by":"publisher","first-page":"1283597","DOI":"10.3389\/fphys.2023.1283597","article-title":"Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications","volume":"14","author":"Zou","year":"2023","journal-title":"Front Physiol"},{"key":"2025081805020867800_bib46","doi-asserted-by":"publisher","first-page":"117610","DOI":"10.1016\/j.cca.2023.117610","article-title":"MicroRNA regulators of vascular pathophysiology in chronic kidney disease","volume":"551","author":"Wu","year":"2023","journal-title":"Clin Chim Acta"},{"key":"2025081805020867800_bib47","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.atherosclerosis.2015.06.037","article-title":"The role of microRNAs in coronary artery disease: from pathophysiology to diagnosis and treatment","volume":"241","author":"Economou","year":"2015","journal-title":"Atherosclerosis"},{"key":"2025081805020867800_bib48","doi-asserted-by":"publisher","first-page":"610561","DOI":"10.3389\/fcvm.2020.610561","article-title":"MiR-223-3p in cardiovascular diseases: a biomarker and potential therapeutic target","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2025081805020867800_bib49","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3389\/fcell.2020.00739","article-title":"Inflammation, senescence and microRNAs in chronic kidney disease","volume":"8","author":"Carmona","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2025081805020867800_bib50","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1038\/s41598-019-41101-8","article-title":"Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients","volume":"9","author":"Fourdinier","year":"2019","journal-title":"Sci Rep"},{"key":"2025081805020867800_bib51","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41371-022-00760-3","article-title":"microRNA-223 and microRNA-126 are clinical indicators for predicting the plaque stability in carotid atherosclerosis patients","volume":"37","author":"Zhu","year":"2023","journal-title":"J Hum Hypertens"},{"key":"2025081805020867800_bib52","doi-asserted-by":"publisher","first-page":"101676","DOI":"10.1016\/j.bonr.2023.101676","article-title":"Effect of age and gender on serum growth differentiation factor 15 and its relationship to bone density and bone turnover","volume":"18","author":"Mattia","year":"2023","journal-title":"Bone Rep"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf223\/63723796\/sfaf223.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/8\/sfaf223\/63723796\/sfaf223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/8\/sfaf223\/63723796\/sfaf223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T09:02:11Z","timestamp":1755507731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf223\/8196182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf223","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,10]]},"article-number":"sfaf223"}}